Treatment of de novo hepatitis C virus-related fibrosing cholestatic hepatitis after orthotopic heart transplantation by ledipasvir and sofosbuvir

by Chen-Hua Liu
Published 2017-05-01

An Exploration of Taiwan’s Military Nationalization Policy Implementation

by Chen-Hua Liu, 劉建華
Published 2007

Using MSN robot for automatic knowledge sharing platform-an example by stock investment

by Chen-Hua Liu, 劉震華
Published 2009

The Study of the Influence of IFRS Adoption on the Relationship between Internal Control Weakness and Quality of Financial Reports

by Chen-Hua Liu, 劉珍華
Published 2014

The Connection between Special Psychology Training and the Psychological Determination and Technical Achievement of Wrestling Athletes

by Chen hua-Liu, 劉振華
Published 2007

Optimizing Treatment for Chronic Hepatitis C Patients with Hepatitis C Virus Genotype 1 Infection

by Chen-Hua Liu, 劉振驊
Published 2015

Sofosbuvir/velpatasvir/voxilaprevir plus ribavirin for chronic hepatitis C patients with direct acting antiviral failures: Implications for viral elimination in Taiwan

by Chen-Hua Liu, Tung-Hung Su, Chun-Jen Liu, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao
Published 2020-12-01

Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients

by Chia-Chi Wang, Chen-Hua Liu, Chih-Lin Lin, Pin-Chao Wang, Tai-Chung Tseng, Hans Hsienhong Lin, Jia-Horng Kao
Published 2015-10-01

Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data

by Chun-Ming Hong, Chen-Hua Liu, Tung-Hung Su, Hung-Chih Yang, Pei-Jer Chen, Yu-Wen Chen, Jia-Horng Kao, Chun-Jen Liu
Published 2020-08-01

Prevalence and clinical implications of IL28B genotypes in Taiwanese patients with chronic hepatitis C

by Yone-Han Mah, Chen-Hua Liu, Chi-Ling Chen, Tai-Chung Tseng, Chun-Jen Liu, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao
Published 2016-11-01

Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection.

by Tung-Hung Su, Chun-Jen Liu, Tai-Chung Tseng, Chen-Hua Liu, Hung-Chih Yang, Chi-Ling Chen, Pei-Jer Chen, Jia-Horng Kao, Ding-Shinn Chen
Published 2013-01-01

Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan.

by Chen-Hua Liu, Chun-Jen Liu, Tung-Hung Su, Hung-Chih Yang, Chun-Ming Hong, Tai-Chung Tseng, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao
Published 2018-01-01

Revisiting the stopping rule for hepatitis C genotype 1 patients treated with peginterferon plus ribavirin.

by Ming-Lung Yu, Chen-Hua Liu, Chung-Feng Huang, Tai-Chung Tseng, Jee-Fu Huang, Chia-Yen Dai, Zu-Yau Lin, Shinn-Cherng Chen, Liang-Yen Wang, Suh-Hang Hank Juo, Wan-Long Chuang, Jia-Horng Kao
Published 2012-01-01

Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE study

by Chen-Hua Liu, Ming-Lung Yu, Cheng-Yuan Peng, Tsai-Yuan Hsieh, Yi-Hsiang Huang, Wei-Wen Su, Pin-Nan Cheng, Chih-Lin Lin, Ching-Chu Lo, Chi-Yi Chen, Jyh-Jou Chen, Qian Ma, Craig Brooks-Rooney, Jia-Horng Kao
Published 2019-06-01

Use of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus infection and severe renal impairment

by Desmond Y. H. Yap, Kevin S. H. Liu, Yu-Chun Hsu, Grace L. H. Wong, Ming-Chang Tsai, Chien-Hung Chen, Ching-Sheng Hsu, Yee Tak Hui, Michael K. K. Li, Chen-Hua Liu, Yee-Man Kan, Ming-Lung Yu, Man-Fung Yuen
Published 2020-10-01

2020 Taiwan consensus statement on the management of hepatitis C: part (I) general populationRecommendationsRecommendationsRecommendationsRecommendationsRecommendationsRecommendati...

by Ming-Lung Yu, Pei-Jer Chen, Chia-Yen Dai, Tsung-Hui Hu, Chung-Feng Huang, Yi-Hsiang Huang, Chao-Hung Hung, Chun-Yen Lin, Chen-Hua Liu, Chun-Jen Liu, Cheng-Yuan Peng, Han-Chieh Lin, Jia-Horng Kao, Wan-Long Chuang
Published 2020-06-01

2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populationsRecommendationsRecommendationsRecommendationsRecommendationsRecommendationsRecommenda...

by Ming-Lung Yu, Pei-Jer Chen, Chia-Yen Dai, Tsung-Hui Hu, Chung-Feng Huang, Yi-Hsiang Huang, Chao-Hung Hung, Chun-Yen Lin, Chen-Hua Liu, Chun-Jen Liu, Cheng-Yuan Peng, Han-Chieh Lin, Jia-Horng Kao, Wan-Long Chuang
Published 2020-07-01

Non-invasive fibrosis algorithms are clinically useful for excluding cirrhosis in prisoners living with hepatitis C

by Timothy Papaluca, Anne Craigie, Lucy McDonald, Amy Edwards, Michael MacIsaac, Jacinta A. Holmes, Matthew Jarman, Tanya Lee, Hannah Huang, Andrew Chan, Mark Lai, Vijaya Sundararajan, Joseph S. Doyle, Margaret Hellard, Mark Stoove, Jessica Howell, Paul Desmond, David Iser, Alexander J. Thompson, Chen-Hua Liu
Published 2020-01-01

Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions

by Ming-Lung Yu, Chao-Hung Hung, Yi-Hsiang Huang, Cheng-Yuan Peng, Chun-Yen Lin, Pin-Nan Cheng, Rong-Nan Chien, Shih-Jer Hsu, Chen-Hua Liu, Chung-Feng Huang, Chien-Wei Su, Jee-Fu Huang, Chun-Jen Liu, Jia-Horng Kao, Wan-Long Chuang, Pei-Jer Chen, Ding-Shinn Chen
Published 2019-02-01

Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis

by Tung-Hung Su, Chung-Wai Shiau, Ping Jao, Nian-Jie Yang, Wei-Tien Tai, Chun-Jen Liu, Tai-Chung Tseng, Hung-Chih Yang, Chen-Hua Liu, Kai-Wen Huang, Ting-Chen Hu, Yu-Jen Huang, Yao-Ming Wu, Li-Ju Chen, Pei-Jer Chen, Ding-Shinn Chen, Kuen-Feng Chen, Jia-Horng Kao
Published 2017-05-01